{"nct_id":"NCT02519452","title":"A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2015-10-22","start_date_type":"ACTUAL","primary_completion_date":"2017-12-13","primary_completion_date_type":"ACTUAL","completion_date":"2023-04-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}